CORE LABORATORIES INC (CLB) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CLB - US21867A1051 - Common Stock
16.49 USD
+0.07 (+0.43%)
16.49 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to CLB. CLB was compared to 60 industry peers in the Energy Equipment & Services industry. While CLB has a great health rating, its profitability is only average at the moment. CLB is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CLB was profitable.
CLB had a positive operating cash flow in the past year.
CLB had positive earnings in 4 of the past 5 years.
In the past 5 years CLB always reported a positive cash flow from operatings.
1.2 Ratios
CLB has a better Return On Assets (5.43%) than 68.33% of its industry peers.
The Return On Equity of CLB (11.84%) is better than 70.00% of its industry peers.
CLB has a Return On Invested Capital of 9.29%. This is in the better half of the industry: CLB outperforms 71.67% of its industry peers.
CLB had an Average Return On Invested Capital over the past 3 years of 8.80%. This is in line with the industry average of 7.66%.
The 3 year average ROIC (8.80%) for CLB is below the current ROIC(9.29%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.43% | ||
| ROE | 11.84% | ||
| ROIC | 9.29% |
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
1.3 Margins
The Profit Margin of CLB (6.21%) is comparable to the rest of the industry.
CLB's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 11.16%, CLB is in line with its industry, outperforming 60.00% of the companies in the same industry.
CLB's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 19.95%, CLB is doing worse than 70.00% of the companies in the same industry.
In the last couple of years the Gross Margin of CLB has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.16% | ||
| PM (TTM) | 6.21% | ||
| GM | 19.95% |
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
2. Health
2.1 Basic Checks
CLB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CLB remains at a similar level compared to 1 year ago.
The number of shares outstanding for CLB has been increased compared to 5 years ago.
The debt/assets ratio for CLB has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.31 indicates that CLB is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 3.31, CLB belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
The Debt to FCF ratio of CLB is 3.32, which is a good value as it means it would take CLB, 3.32 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CLB (3.32) is better than 65.00% of its industry peers.
CLB has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.42, CLB perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 3.32 | ||
| Altman-Z | 3.31 |
ROIC/WACC1.06
WACC8.77%
2.3 Liquidity
CLB has a Current Ratio of 2.37. This indicates that CLB is financially healthy and has no problem in meeting its short term obligations.
CLB's Current ratio of 2.37 is fine compared to the rest of the industry. CLB outperforms 68.33% of its industry peers.
A Quick Ratio of 1.76 indicates that CLB should not have too much problems paying its short term obligations.
CLB has a Quick ratio of 1.76. This is in the better half of the industry: CLB outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.76 |
3. Growth
3.1 Past
CLB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.41%.
Measured over the past years, CLB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.14% on average per year.
CLB shows a decrease in Revenue. In the last year, the revenue decreased by -1.02%.
CLB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.75% yearly.
EPS 1Y (TTM)-9.41%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-12%
Revenue 1Y (TTM)-1.02%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.09%
3.2 Future
The Earnings Per Share is expected to grow by 12.78% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.47% on average over the next years.
EPS Next Y-17.36%
EPS Next 2Y-6.19%
EPS Next 3Y-0.94%
EPS Next 5Y12.78%
Revenue Next Year-2.55%
Revenue Next 2Y-1.69%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 21.42 indicates a rather expensive valuation of CLB.
Compared to the rest of the industry, the Price/Earnings ratio of CLB is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 26.41. CLB is around the same levels.
Based on the Price/Forward Earnings ratio of 21.29, the valuation of CLB can be described as rather expensive.
CLB's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of CLB to the average of the S&P500 Index (35.40), we can say CLB is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.42 | ||
| Fwd PE | 21.29 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CLB is valued more expensive than 85.00% of the companies in the same industry.
CLB's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.33 | ||
| EV/EBITDA | 11.78 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.19%
EPS Next 3Y-0.94%
5. Dividend
5.1 Amount
CLB has a yearly dividend return of 0.27%, which is pretty low.
Compared to an average industry Dividend Yield of 2.95, CLB has a dividend in line with its industry peers.
With a Dividend Yield of 0.27, CLB pays less dividend than the S&P500 average, which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.27% |
5.2 History
The dividend of CLB decreases each year by -55.13%.
CLB has been paying a dividend for at least 10 years, so it has a reliable track record.
CLB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-55.13%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
CLB pays out 5.83% of its income as dividend. This is a sustainable payout ratio.
DP5.83%
EPS Next 2Y-6.19%
EPS Next 3Y-0.94%
16.49
+0.07 (+0.43%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)
Earnings (Next)
Inst Owners114.84%
Inst Owner Change-3.59%
Ins Owners1.04%
Ins Owner Change0.07%
Market Cap767.77M
Revenue(TTM)517.50M
Net Income(TTM)32.12M
Analysts48
Price Target15.64 (-5.15%)
Short Float %10.3%
Short Ratio8.28
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.27% |
Yearly Dividend0.04
Dividend Growth(5Y)-55.13%
DP5.83%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.26%
Min EPS beat(2)-0.33%
Max EPS beat(2)12.86%
EPS beat(4)1
Avg EPS beat(4)1.9%
Min EPS beat(4)-4.67%
Max EPS beat(4)12.86%
EPS beat(8)4
Avg EPS beat(8)4.82%
EPS beat(12)7
Avg EPS beat(12)5.16%
EPS beat(16)8
Avg EPS beat(16)3.39%
Revenue beat(2)2
Avg Revenue beat(2)0.73%
Min Revenue beat(2)0.02%
Max Revenue beat(2)1.44%
Revenue beat(4)2
Avg Revenue beat(4)-0.96%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)1.44%
Revenue beat(8)3
Avg Revenue beat(8)-0.5%
Revenue beat(12)4
Avg Revenue beat(12)-1.2%
Revenue beat(16)5
Avg Revenue beat(16)-1.06%
PT rev (1m)0%
PT rev (3m)11.51%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.83%
EPS NY rev (1m)-4.09%
EPS NY rev (3m)-3.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0.15%
Revenue NY rev (3m)0.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.42 | ||
| Fwd PE | 21.29 | ||
| P/S | 1.48 | ||
| P/FCF | 22.33 | ||
| P/OCF | 15.45 | ||
| P/B | 2.83 | ||
| P/tB | 4.65 | ||
| EV/EBITDA | 11.78 |
EPS(TTM)0.77
EY4.67%
EPS(NY)0.77
Fwd EY4.7%
FCF(TTM)0.74
FCFY4.48%
OCF(TTM)1.07
OCFY6.47%
SpS11.11
BVpS5.83
TBVpS3.55
PEG (NY)N/A
PEG (5Y)N/A
Graham Number10.05
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.43% | ||
| ROE | 11.84% | ||
| ROCE | 11.66% | ||
| ROIC | 9.29% | ||
| ROICexc | 9.8% | ||
| ROICexgc | 12.66% | ||
| OM | 11.16% | ||
| PM (TTM) | 6.21% | ||
| GM | 19.95% | ||
| FCFM | 6.64% |
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
ROICexc(3y)9.11%
ROICexc(5y)8.99%
ROICexgc(3y)11.75%
ROICexgc(5y)11.63%
ROCE(3y)11.03%
ROCE(5y)10.9%
ROICexgc growth 3Y11.32%
ROICexgc growth 5Y-6.37%
ROICexc growth 3Y11.52%
ROICexc growth 5Y-2.86%
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
F-Score7
Asset Turnover0.88
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 3.32 | ||
| Debt/EBITDA | 1.58 | ||
| Cap/Depr | 104.6% | ||
| Cap/Sales | 2.96% | ||
| Interest Coverage | 6.66 | ||
| Cash Conversion | 68.62% | ||
| Profit Quality | 107.03% | ||
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.76 | ||
| Altman-Z | 3.31 |
F-Score7
WACC8.77%
ROIC/WACC1.06
Cap/Depr(3y)71.15%
Cap/Depr(5y)68.67%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.39%
Profit Quality(3y)84.24%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.41%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-12%
EPS Next Y-17.36%
EPS Next 2Y-6.19%
EPS Next 3Y-0.94%
EPS Next 5Y12.78%
Revenue 1Y (TTM)-1.02%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.09%
Revenue Next Year-2.55%
Revenue Next 2Y-1.69%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
EBIT growth 1Y-6.83%
EBIT growth 3Y11.62%
EBIT growth 5Y-8.87%
EBIT Next Year10.01%
EBIT Next 3Y4.07%
EBIT Next 5Y17.46%
FCF growth 1Y286.32%
FCF growth 3Y23.36%
FCF growth 5Y-8.39%
OCF growth 1Y165.78%
OCF growth 3Y15.5%
OCF growth 5Y-8.83%
CORE LABORATORIES INC / CLB FAQ
Can you provide the ChartMill fundamental rating for CORE LABORATORIES INC?
ChartMill assigns a fundamental rating of 5 / 10 to CLB.
What is the valuation status for CLB stock?
ChartMill assigns a valuation rating of 2 / 10 to CORE LABORATORIES INC (CLB). This can be considered as Overvalued.
Can you provide the profitability details for CORE LABORATORIES INC?
CORE LABORATORIES INC (CLB) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for CLB stock?
The Price/Earnings (PE) ratio for CORE LABORATORIES INC (CLB) is 21.42 and the Price/Book (PB) ratio is 2.83.
Can you provide the financial health for CLB stock?
The financial health rating of CORE LABORATORIES INC (CLB) is 7 / 10.